MEVOPUR Chemical Foaming Agents Application Bulletin_CN 可持续发展关注的焦点 应用公告 用于医疗器械和药品包装的 MEVOPUR 化学发泡剂（CFA）™ 随着将可持续性融入医疗保健产品设计的需求不 断增长，医疗器械和药品包装制造商正在寻找更 环保的材料。 埃万特依托在汽车塑料部件用化学发泡剂 和医疗保健应用聚合物解决方案开发方面的综合 经验，最终开发出MEVOPUR 化学发泡剂。

经预测 试的琥珀色着色剂是Mevopur™产品组合中的一 员，可应用于PET药水瓶、瓶子和其他包装产 品。 我们公布了埃万特的Mevopur™产品政策和使用限制，以帮助客户选择产品，同时践行我们的承诺。 请注意，埃万特的Mevopur产品并不适用于某些应用，也不提倡或计划用于：包括但不限于长期或永久性植入物、节育器或整形手术。

Mevopur™ Healthcare Functional Additives Laser Marking Additives for Medical Devices and Pharmaceutical Packaging Laser marking offers several advantages compared to other marking technologies. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Colorants and Formulations Mevopur™ Healthcare Bio-based Polymer Solutions

Mevopur™ Healthcare Colorants and Formulations Special Effect Colorants for Healthcare Devices and Pharmaceutical Packaging Self-administered medication, for example via pen devices and inhalers, has been the norm for many years. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Mevopur™ Healthcare Functional Additives for Medical Devices and Diagnostic Equipment Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in applications, such as medical housings, drug delivery devices, syringes and needles, diagnostics, and catheters. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Mevopur™ Healthcare Functional Additives for Pharmaceutical Packaging Mevopur™ Healthcare Functional Additives help protect and enhance the performance of polymers used in pharmaceutical packaging products such as vials, bottles, closure systems, films and combination devices. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Mevopur™ Healthcare Bio-based Polymer Solutions for Medical Devices and Pharmaceutical Packaging Manufacturers of medical devices and pharmaceutical packaging are increasingly faced with the challenge of integrating sustainability into the design of their products. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives

Requirements: Skin contact colorant certified for ISO 10993 biocompatibility Solution: OnColor™ HC Plus, MEVOPUR® 5. Requirements: Dark mark for rapid labeling Solution: OnCap™ Fast Mark™ Laser Marking Additives, MEVOPUR® 6. Requirements: USP Class VI skin contact colorant for drug differentiation Solution: OnColor™ HC, MEVOPUR® 4 Button 5 Batch or SKU identifier Safety and trigger cap 6 DRUG CONCENTRATION 1 DRUG CONCENTRATION 2 DRUG CONCENTRATION 3 Patient Handling Age or certain disease states can severely limit patient dexterity making the self-administration of medication difficult and frustrating.